{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:37:28Z","timestamp":1773365848845,"version":"3.50.1"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s11910-022-01203-9","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T08:02:43Z","timestamp":1652947363000},"page":"363-374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neurological Manifestations of Myocarditis"],"prefix":"10.1007","volume":"22","author":[{"given":"Gabriela","family":"Trifan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando D.","family":"Testai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"issue":"7","key":"1203_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1161\/CIRCRESAHA.117.310221","volume":"121","author":"BH Trachtenberg","year":"2017","unstructured":"Trachtenberg BH, Hare JM. Inflammatory cardiomyopathic syndromes. Circ Res. 2017;121(7):803\u201318.","journal-title":"Circ Res"},{"key":"1203_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-3-030-35276-9_2","volume-title":"Myocarditis: pathogenesis, diagnosis and treatment","author":"ALP Caforio","year":"2020","unstructured":"Caforio ALP, Marcolongo R, Cheng C-Y, Baritussio A, Tarantini G, Iliceto S. Clinical presentation of myocarditis. In: Caforio ALP, editor. Myocarditis: pathogenesis, diagnosis and treatment. Cham: Springer International Publishing; 2020. p. 19\u201336. Comprehensive overview of myocarditis"},{"issue":"11","key":"1203_CR3","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1161\/CIRCULATIONAHA.118.035319","volume":"138","author":"E Ammirati","year":"2018","unstructured":"Ammirati E, Cipriani M, Moro C, Raineri C, Pini D, Sormani P, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis. Circulation. 2018;138(11):1088\u201399.","journal-title":"Circulation"},{"issue":"11","key":"1203_CR4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nrcardio.2015.108","volume":"12","author":"A Pollack","year":"2015","unstructured":"Pollack A, Kontorovich AR, Fuster V, Dec GW. Viral myocarditis\u2013diagnosis, treatment options, and current controversies. Nat Rev Cardiol. 2015;12(11):670\u201380.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"1203_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ccl.2007.08.008","volume":"25","author":"C Basso","year":"2007","unstructured":"Basso C, Carturan E, Corrado D, Thiene G. Myocarditis and dilated cardiomyopathy in athletes: diagnosis, management, and recommendations for sport activity. Cardiol Clin. 2007;25(3):423\u20139, vi.","journal-title":"Cardiol Clin."},{"issue":"21","key":"1203_CR6","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1016\/j.jacc.2015.09.035","volume":"66","author":"BJ Maron","year":"2015","unstructured":"Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NAM 3rd, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2362\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"1203_CR7","first-page":"1","volume-title":"Myocarditis: pathogenesis, diagnosis and treatment","author":"S Rizzo","year":"2020","unstructured":"Rizzo S, Carturan E, Thiene G, Basso C. Classification, histopathology, immunohistology, and molecular diagnosis of myocarditis. In: Caforio ALP, editor. Myocarditis: pathogenesis, diagnosis and treatment. Cham: Springer International Publishing; 2020. p. 1\u201317."},{"issue":"11","key":"1203_CR8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1136\/heartjnl-2012-301686","volume":"98","author":"C Elamm","year":"2012","unstructured":"Elamm C, Fairweather D, Cooper LT. Pathogenesis and diagnosis of myocarditis. Heart. 2012;98(11):835\u201340.","journal-title":"Heart"},{"issue":"1","key":"1203_CR9","first-page":"3","volume":"1","author":"HT Aretz","year":"1987","unstructured":"Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1(1):3\u201314.","journal-title":"Am J Cardiovasc Pathol."},{"issue":"33","key":"1203_CR10","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"ALP Caforio","year":"2013","unstructured":"Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636\u201348.","journal-title":"Eur Heart J"},{"issue":"14","key":"1203_CR11","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies. Circulation. 2006;113(14):1807\u201316.","journal-title":"Circulation"},{"issue":"11","key":"1203_CR12","first-page":"e007405","volume":"13","author":"E Ammirati","year":"2020","unstructured":"Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy. Circulation: Heart Failure. 2020;13(11):e007405.\u00a0Comprehensive overview discussing current management of acute and chronic heart failure.","journal-title":"Circulation: Heart Failure"},{"issue":"11","key":"1203_CR13","doi-asserted-by":"publisher","first-page":"e007405-e","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","volume":"13","author":"E Ammirati","year":"2020","unstructured":"Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circulation Heart failure. 2020;13(11):e007405-e.","journal-title":"Circulation Heart failure"},{"issue":"11","key":"1203_CR14","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/CIRCRESAHA.118.313578","volume":"124","author":"C Tsch\u00f6pe","year":"2019","unstructured":"Tsch\u00f6pe C, Cooper LT, Torre-Amione G, Linthout SV. Management of myocarditis-related cardiomyopathy in adults. Circ Res. 2019;124(11):1568\u201383.","journal-title":"Circ Res"},{"issue":"3","key":"1203_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0735-1097(03)00648-X","volume":"42","author":"NE Bowles","year":"2003","unstructured":"Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss H-P, McCarthy R, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. J Am Coll Cardiol. 2003;42(3):466\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1203_CR16","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/01.CIR.0000155616.07901.35","volume":"111","author":"U K\u00fchl","year":"2005","unstructured":"K\u00fchl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \u201cidiopathic\u201d left ventricular dysfunction. Circulation. 2005;111(7):887\u201393.","journal-title":"Circulation"},{"issue":"9","key":"1203_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1191\/0961203305lu2192oa","volume":"14","author":"D Fairweather","year":"2005","unstructured":"Fairweather D, Rose NR. Inflammatory heart disease: a role for cytokines. Lupus. 2005;14(9):646\u201351.","journal-title":"Lupus"},{"issue":"1","key":"1203_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4049\/jimmunol.0800861","volume":"183","author":"P Zhang","year":"2009","unstructured":"Zhang P, Cox CJ, Alvarez KM, Cunningham MW. Cutting edge: cardiac myosin activates innate immune responses through TLRs. J Immunol. 2009;183(1):27\u201331.","journal-title":"J Immunol"},{"issue":"13","key":"1203_CR19","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1161\/CIRCULATIONAHA.105.548156","volume":"112","author":"U K\u00fchl","year":"2005","unstructured":"K\u00fchl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 2005;112(13):1965\u201370.","journal-title":"Circulation"},{"issue":"9","key":"1203_CR20","doi-asserted-by":"publisher","first-page":"e009487","DOI":"10.1161\/CIRCIMAGING.119.009487","volume":"12","author":"KM Kassem","year":"2019","unstructured":"Kassem KM, Souka A, Harris DM, Parajuli S, Cook JL. Eosinophilic myocarditis. Circulation. Cardiovascular Imaging. 2019;12(9):e009487.","journal-title":"Cardiovascular Imaging"},{"key":"1203_CR21","first-page":"437","volume-title":"Myocarditis: from bench to bedside","author":"LA Wu","year":"2003","unstructured":"Wu LA, Cooper LT, Kephart GM, Gleich GJ. The eosinophil in cardiac disease. In: Cooper LT, editor. Myocarditis: from bench to bedside. Totowa, NJ: Humana Press; 2003. p. 437\u201353."},{"key":"1203_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/BF02072402","volume":"1","author":"CJ Spry","year":"1985","unstructured":"Spry CJ, Take M, Tai PC. Eosinophilic disorders affecting the myocardium and endocardium: a review. Heart Vessels Suppl. 1985;1:240\u20132.","journal-title":"Heart Vessels Suppl"},{"issue":"21","key":"1203_CR23","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1182\/blood.2019000518","volume":"134","author":"C Marx","year":"2019","unstructured":"Marx C, Novotny J, Salbeck D, Zellner KR, Nicolai L, Pekayvaz K, et al. Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps. Blood. 2019;134(21):1859\u201372.","journal-title":"Blood"},{"issue":"12","key":"1203_CR24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.5858\/arpa.2016-0068-RS","volume":"140","author":"J Xu","year":"2016","unstructured":"Xu J, Brooks EG. Giant cell myocarditis: a brief review. Arch Pathol Lab Med. 2016;140(12):1429\u201334.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"1203_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijcard.2005.03.075","volume":"102","author":"MM Kittleson","year":"2005","unstructured":"Kittleson MM, Minhas KM, Irizarry RA, Ye SQ, Edness G, Breton E, et al. Gene expression in giant cell myocarditis: altered expression of immune response genes. Int J Cardiol. 2005;102(2):333\u201340.","journal-title":"Int J Cardiol"},{"issue":"4","key":"1203_CR26","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S0008-6363(00)00142-5","volume":"47","author":"JK Dam\u00e5s","year":"2000","unstructured":"Dam\u00e5s JK, Eiken HG, \u00d8ie E, Bjerkeli V, Yndestad A, Ueland T, et al. Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovasc Res. 2000;47(4):778\u201387.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"1203_CR27","doi-asserted-by":"publisher","first-page":"e020542","DOI":"10.1161\/JAHA.121.020542","volume":"10","author":"DH Birnie","year":"2021","unstructured":"Birnie DH, Nair V, Veinot JP. Cardiac sarcoidosis and giant cell myocarditis: actually, 2 ends of the same disease? J Am Heart Assoc. 2021;10(6):e020542.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1203_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0735-1097(02)02715-8","volume":"41","author":"Y Okura","year":"2003","unstructured":"Okura Y, Dec GW, Hare JM, Kodama M, Berry GJ, Tazelaar HD, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol. 2003;41(2):322\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1203_CR29","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.amjmed.2019.10.015","volume":"133","author":"A Younis","year":"2020","unstructured":"Younis A, Matetzky S, Mulla W, Masalha E, Afel Y, Chernomordik F, et al. Epidemiology characteristics and outcome of patients with clinically diagnosed acute myocarditis. Am J Med. 2020;133(4):492\u20139.","journal-title":"Am J Med"},{"issue":"4","key":"1203_CR30","first-page":"676","volume":"6","author":"MK Bennett","year":"2013","unstructured":"Bennett MK, Gilotra NA, Harrington C, Rao S, Dunn JM, Freitag TB, et al. Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000\u20132009. Circulation: Heart Failure. 2013;6(4):676\u201384.","journal-title":"Circulation: Heart Failure."},{"issue":"24","key":"1203_CR31","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24):3158\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"1203_CR32","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1136\/heartjnl-2018-314631","volume":"105","author":"S Bhatia","year":"2019","unstructured":"Bhatia S, Anstine C, Jaffe AS, Gersh BJ, Chandrasekaran K, Foley TA, et al. Cardiac magnetic resonance in patients with elevated troponin and normal coronary angiography. Heart. 2019;105(16):1231\u20136.","journal-title":"Heart"},{"issue":"3","key":"1203_CR33","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1161\/CIRCRESAHA.116.308446","volume":"120","author":"P Tahsili-Fahadan","year":"2017","unstructured":"Tahsili-Fahadan P, Geocadin RG. Heart\u2013brain axis. Circ Res. 2017;120(3):559\u201372 Review article discussing the interplay between brain and heart connection.","journal-title":"Circ Res"},{"issue":"3","key":"1203_CR34","first-page":"261","volume":"83","author":"J-A Palma","year":"2014","unstructured":"Palma J-A, Benarroch EE. Neural control of the heart. Recent concepts and clinical correlations. 2014;83(3):261\u201371.","journal-title":"Recent concepts and clinical correlations"},{"issue":"3","key":"1203_CR35","first-page":"266","volume":"8","author":"MM Manea","year":"2015","unstructured":"Manea MM, Comsa M, Minca A, Dragos D, Popa C. Brain-heart axis\u2013review article. J Med Life. 2015;8(3):266\u201371.","journal-title":"J Med Life"},{"issue":"1","key":"1203_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-197501000-00001","volume":"54","author":"MJ Chusid","year":"1975","unstructured":"Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975;54(1):1\u201327.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1203_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1586\/ehm.12.14","volume":"5","author":"E Cogan","year":"2012","unstructured":"Cogan E, Roufosse F. Clinical management of the hypereosinophilic syndromes. Expert Rev Hematol. 2012;5(3):275\u201390.","journal-title":"Expert Rev Hematol"},{"key":"1203_CR38","first-page":"817","volume":"66","author":"W Loeffler","year":"1936","unstructured":"Loeffler W. Endocarditis parietalis mit Bluteosinophilie. Ein eigenartiges Krankheitsbild Schweiz Med Wochenschr. 1936;66:817.","journal-title":"Ein eigenartiges Krankheitsbild Schweiz Med Wochenschr"},{"issue":"10","key":"1203_CR39","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","volume":"83","author":"PF Weller","year":"1994","unstructured":"Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994;83(10):2759\u201379.","journal-title":"Blood"},{"issue":"1","key":"1203_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.7326\/0003-4819-102-1-109","volume":"102","author":"PM Moore","year":"1985","unstructured":"Moore PM, Harley JB, Fauci AS. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med. 1985;102(1):109\u201314.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1203_CR41","first-page":"167","volume":"119","author":"A Perry","year":"1995","unstructured":"Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med. 1995;119(2):167\u201372.","journal-title":"Arch Pathol Lab Med."},{"issue":"4","key":"1203_CR42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.15420\/aer.2020.09","volume":"9","author":"N Gilotra","year":"2020","unstructured":"Gilotra N, Okada D, Sharma A, Chrispin J. Management of cardiac sarcoidosis in 2020. Arrhythm Electrophysiol Rev. 2020;9(4):182\u20138.","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"6","key":"1203_CR43","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","volume":"58","author":"KJ Silverman","year":"1978","unstructured":"Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58(6):1204\u201311.","journal-title":"Circulation"},{"issue":"5","key":"1203_CR44","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ihj.2020.07.015","volume":"72","author":"M Subramanian","year":"2020","unstructured":"Subramanian M, Yalagudri S, Saggu D, Kishore J, Reddy M, Narasimhan C. Stroke in cardiac sarcoidosis: need to worry? Indian Heart J. 2020;72(5):442\u20134.","journal-title":"Indian Heart J"},{"issue":"17","key":"1203_CR45","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1113\/jphysiol.2011.212886","volume":"589","author":"B Nieswandt","year":"2011","unstructured":"Nieswandt B, Kleinschnitz C, Stoll G. Ischaemic stroke: a thrombo-inflammatory disease? J Physiol. 2011;589(17):4115\u201323.","journal-title":"J Physiol"},{"issue":"5","key":"1203_CR46","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1189\/jlb.1109766","volume":"87","author":"R Jin","year":"2010","unstructured":"Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010;87(5):779\u201389.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1203_CR47","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1378\/chest.103.1.253","volume":"103","author":"OP Sharma","year":"1993","unstructured":"Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest. 1993;103(1):253\u20138.","journal-title":"Chest"},{"issue":"1","key":"1203_CR48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/ijn.IJN_12_18","volume":"29","author":"M Nagarajan","year":"2019","unstructured":"Nagarajan M, Maasila AT, Dhanapriya J, Dineshkumar T, Sakthirajan R, Rajasekar D, et al. Systemic lupus erythematosus and myasthenia gravis: a rare association. Indian J Nephrol. 2019;29(1):62\u20134.","journal-title":"Indian J Nephrol"},{"issue":"1","key":"1203_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41983-020-0149-9","volume":"56","author":"H Herath","year":"2020","unstructured":"Herath H, Kulatunga A. Systemic lupus erythematosus presenting with status epilepticus and acute cardiomyopathy with acute heart failure: case report. Egypt J Neurol Psychiatr Neurosurg. 2020;56(1):15.","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"1203_CR50","first-page":"6498315","volume":"2019","author":"WDD Priyankara","year":"2019","unstructured":"Priyankara WDD, Manoj EM. Posterior reversible encephalopathy in a patient with severe leptospirosis complicated with pulmonary haemorrhage, myocarditis, and acute kidney injury. Case Rep Crit Care. 2019;2019:6498315.","journal-title":"Case Rep Crit Care"},{"issue":"2","key":"1203_CR51","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1016\/j.ijcard.2013.12.275","volume":"172","author":"R Lorusso","year":"2014","unstructured":"Lorusso R, Vizzardi E, Pinelli L, Gelsomino S. Posterior reversible encephalopathy syndrome in a patient submitted to extracorporeal membrane oxygenation for acute fulminant myocarditis. Int J Cardiol. 2014;172(2):e329\u201330.","journal-title":"Int J Cardiol"},{"issue":"11","key":"1203_CR52","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1172\/JCI29894","volume":"116","author":"BM Conti-Fine","year":"2006","unstructured":"Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest. 2006;116(11):2843\u201354.","journal-title":"J Clin Invest"},{"issue":"11","key":"1203_CR53","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/archneurol.2009.229","volume":"66","author":"S Suzuki","year":"2009","unstructured":"Suzuki S, Utsugisawa K, Yoshikawa H, Motomura M, Matsubara S, Yokoyama K, et al. Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Arch Neurol. 2009;66(11):1334\u20138.","journal-title":"Arch Neurol"},{"key":"1203_CR54","doi-asserted-by":"crossref","unstructured":"Santos E, Coutinho E, Martins da Silva A, Marinho A, Vasconcelos C, Taipa R, et al. Inflammatory myopathy associated with myasthenia gravis with and without thymic pathology: report of four cases and literature review. Autoimmun Rev. 2017;16(6):644\u20139","DOI":"10.1016\/j.autrev.2017.04.009"},{"issue":"8","key":"1203_CR55","doi-asserted-by":"publisher","first-page":"e2242","DOI":"10.1002\/brb3.2242","volume":"11","author":"W Cheng","year":"2021","unstructured":"Cheng W, Sun T, Liu C, Zhou Z, Duan J, Zhao Y, et al. A systematic review of myasthenia gravis complicated with myocarditis. Brain and Behavior. 2021;11(8):e2242.\u00a0Systematic review where the connections between myocarditis, myasthenia gravis, and immune checkpoint inhibitors are explored.","journal-title":"Brain and Behavior"},{"issue":"11","key":"1203_CR56","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","volume":"376","author":"J Bellmunt","year":"2017","unstructured":"Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, et al. Pembrolizumab as second-line therapy for advanced urothelial carcinoma. N Engl J Med. 2017;376(11):1015\u201326.","journal-title":"N Engl J Med"},{"issue":"11","key":"1203_CR57","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1212\/WNL.0000000000004359","volume":"89","author":"S Suzuki","year":"2017","unstructured":"Suzuki S, Ishikawa N, Konoeda F, Seki N, Fukushima S, Takahashi K, et al. Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan. Neurology. 2017;89(11):1127\u201334.","journal-title":"Neurology"},{"issue":"18","key":"1203_CR58","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","volume":"375","author":"DB Johnson","year":"2016","unstructured":"Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y, et al. Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med. 2016;375(18):1749\u201355.","journal-title":"N Engl J Med"},{"issue":"9","key":"1203_CR59","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.3390\/ijms21093054","volume":"21","author":"AG Solimando","year":"2020","unstructured":"Solimando AG, Crudele L, Leone P, Argentiero A, Guarascio M, Silvestris N, et al. Immune checkpoint inhibitor-related myositis: from biology to bedside. Int J Mol Sci. 2020;21(9):3054.","journal-title":"Int J Mol Sci"},{"key":"1203_CR60","doi-asserted-by":"publisher","first-page":"101145","DOI":"10.1016\/j.eucr.2020.101145","volume":"31","author":"M Takai","year":"2020","unstructured":"Takai M, Kato D, Iinuma K, Maekawa YM, Nakane K, Tsuchiya T, et al. Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: a case report. Urol Case Rep. 2020;31:101145.","journal-title":"Urol Case Rep"},{"issue":"10","key":"1203_CR61","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.4103\/jfmpc.jfmpc_232_21","volume":"10","author":"N Kaeley","year":"2021","unstructured":"Kaeley N, Chawang HJ, Baid H, Pillai A. Cardiovascular manifestations of COVID-19: a case series. J Family Med Prim Care. 2021;10(10):3930\u20134.","journal-title":"J Family Med Prim Care"},{"issue":"1","key":"1203_CR62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1055\/s-0041-1732364","volume":"53","author":"G Brisca","year":"2022","unstructured":"Brisca G, Sotgiu S, Pirlo D, Tubino B, Siri L, Chianucci B, et al. Longitudinally extensive transverse myelitis (LETM) and myopericarditis in a 7-month-old child with SARs-CoV-2 infection. Neuropediatrics. 2022;53(1):61\u20134.","journal-title":"Neuropediatrics"},{"issue":"1","key":"1203_CR63","doi-asserted-by":"publisher","first-page":"e240095","DOI":"10.1136\/bcr-2020-240095","volume":"14","author":"EH Dahl","year":"2021","unstructured":"Dahl EH, Mosevoll KA, Cramariuc D, Vedeler CA, Blomberg B. COVID-19 myocarditis and postinfection Bell\u2019s palsy. BMJ Case Rep. 2021;14(1):e240095. https:\/\/doi.org\/10.1136\/bcr-2020-240095.","journal-title":"BMJ Case Rep."},{"key":"1203_CR64","doi-asserted-by":"publisher","first-page":"102887","DOI":"10.1016\/j.ebiom.2020.102887","volume":"58","author":"P Domingo","year":"2020","unstructured":"Domingo P, Mur I, Pomar V, Corominas H, Casademont J, de Benito N. The four horsemen of a viral apocalypse: the pathogenesis of SARS-CoV-2 infection (COVID-19). EBioMedicine. 2020;58:102887.","journal-title":"EBioMedicine"},{"issue":"1","key":"1203_CR65","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13195-020-00744-w","volume":"12","author":"S Miners","year":"2020","unstructured":"Miners S, Kehoe PG, Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimer\u2019s Research & Therapy. 2020;12(1):170.","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"9","key":"1203_CR66","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.hrthm.2020.05.001","volume":"17","author":"B Siripanthong","year":"2020","unstructured":"Siripanthong B, Nazarian S, Muser D, Deo R, Santangeli P, Khanji MY, et al. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463\u201371.\u00a0Article exploring the relationship between COVID-19 disease and myocarditis and proposes few pathogenetic mechanisms.","journal-title":"Heart Rhythm"},{"issue":"4","key":"1203_CR67","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601\u201315.","journal-title":"Nat Med"},{"issue":"2","key":"1203_CR68","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/cells10020386","volume":"10","author":"B Sun","year":"2021","unstructured":"Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, et al. Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells. 2021;10(2):386.","journal-title":"Cells"},{"key":"1203_CR69","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jpsychires.2020.06.022","volume":"129","author":"H Zhou","year":"2020","unstructured":"Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu H, et al. The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res. 2020;129:98\u2013102.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1203_CR70","first-page":"1003","volume":"1","author":"D Kempuraj","year":"2016","unstructured":"Kempuraj D, Thangavel R, Natteru PA, Selvakumar GP, Saeed D, Zahoor H, et al. Neuroinflammation induces neurodegeneration. J Neurol Neurosurg Spine. 2016;1(1):1003.","journal-title":"J Neurol Neurosurg Spine"},{"issue":"3","key":"1203_CR71","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/jnc.13411","volume":"136","author":"MR Minter","year":"2016","unstructured":"Minter MR, Taylor JM, Crack PJ. The contribution of neuroinflammation to amyloid toxicity in Alzheimer\u2019s disease. J Neurochem. 2016;136(3):457\u201374.","journal-title":"J Neurochem"},{"issue":"7","key":"1203_CR72","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S1474-4422(21)00168-X","volume":"20","author":"J Pratt","year":"2021","unstructured":"Pratt J, Lester E, Parker R. Could SARS-CoV-2 cause tauopathy? Lancet Neurol. 2021;20(7):506.","journal-title":"Lancet Neurol"},{"issue":"24","key":"1203_CR73","doi-asserted-by":"publisher","first-page":"13603","DOI":"10.3390\/ijms222413603","volume":"22","author":"L Chiricosta","year":"2021","unstructured":"Chiricosta L, Gugliandolo A, Mazzon E. SARS-CoV-2 exacerbates beta-amyloid neurotoxicity, inflammation and oxidative stress in Alzheimer\u2019s disease patients. Int J Mol Sci. 2021;22(24):13603. https:\/\/doi.org\/10.3390\/ijms222413603.","journal-title":"Int J Mol Sci."},{"issue":"10","key":"1203_CR74","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1001\/jamacardio.2021.2833","volume":"6","author":"J Montgomery","year":"2021","unstructured":"Montgomery J, Ryan M, Engler R, Hoffman D, McClenathan B, Collins L, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. 2021;6(10):1202\u20136.","journal-title":"JAMA Cardiol"},{"issue":"6","key":"1203_CR75","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1161\/CIRCULATIONAHA.121.055913","volume":"144","author":"KF Larson","year":"2021","unstructured":"Larson KF, Ammirati E, Adler ED, Cooper LT Jr, Hong KN, Saponara G, et al. Myocarditis after BNT162b2 and mRNA-1273 vaccination. Circulation. 2021;144(6):506\u20138.\u00a0Case series and review of the possible association between SARS-CoV-2 vaccination and myocarditis.","journal-title":"Circulation"},{"issue":"6","key":"1203_CR76","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.121.055891","volume":"144","author":"CM Rosner","year":"2021","unstructured":"Rosner CM, Genovese L, Tehrani BN, Atkins M, Bakhshi H, Chaudhri S, et al. Myocarditis temporally associated with COVID-19 vaccination. Circulation. 2021;144(6):502\u20135.","journal-title":"Circulation"},{"issue":"22","key":"1203_CR77","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/eurheartj\/ehy076","volume":"39","author":"J-R Ghadri","year":"2018","unstructured":"Ghadri J-R, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, et al. International expert consensus document on Takotsubo syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. 2018;39(22):2032\u201346.","journal-title":"Eur Heart J"},{"issue":"24","key":"1203_CR78","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.116.027121","volume":"135","author":"F Pelliccia","year":"2017","unstructured":"Pelliccia F, Kaski JC, Crea F, Camici PG. Pathophysiology of Takotsubo syndrome. Circulation. 2017;135(24):2426\u201341.","journal-title":"Circulation"},{"key":"1203_CR79","doi-asserted-by":"publisher","unstructured":"Lachmet-Thebaud L, Marchandot B, Matsushita K, Sato C, Dagrenat C, Greciano S, et al. Residual inflammation is a major determinant of myocardial recovery and cardiovascular outcome in Takotsubo patients. Eur Heart J.\u00a02020;41(Supplement_2):ehaa946.1835. https:\/\/doi.org\/10.1093\/ehjci\/ehaa946.1835.","DOI":"10.1093\/ehjci\/ehaa946.1835"},{"issue":"13","key":"1203_CR80","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.118.037975","volume":"139","author":"C Scally","year":"2019","unstructured":"Scally C, Abbas H, Ahearn T, Srinivasan J, Mezincescu A, Rudd A, et al. Myocardial and systemic inflammation in acute stress-induced (Takotsubo) cardiomyopathy. Circulation. 2019;139(13):1581\u201392.","journal-title":"Circulation"},{"issue":"2","key":"1203_CR81","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijcard.2014.08.101","volume":"177","author":"J Finsterer","year":"2014","unstructured":"Finsterer J, Wahbi K. CNS disease triggering Takotsubo stress cardiomyopathy. Int J Cardiol. 2014;177(2):322\u20139.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1203_CR82","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12883-020-01757-6","volume":"20","author":"D Rapp","year":"2020","unstructured":"Rapp D, Kessler M, Pinkhardt E, Otto M, Tumani H, Senel M. Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case report. BMC Neurol. 2020;20(1):227.","journal-title":"BMC Neurol"},{"issue":"5","key":"1203_CR83","first-page":"499","volume":"85","author":"A D\u2019Ambrosio","year":"2001","unstructured":"D\u2019Ambrosio A, Patti G, Manzoli A, Sinagra G, Di Lenarda A, Silvestri F, et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart. 2001;85(5):499\u2013504.","journal-title":"Heart"},{"issue":"12","key":"1203_CR84","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1160\/TH12-08-0578","volume":"108","author":"GYH Lip","year":"2012","unstructured":"Lip GYH, Ponikowski P, Andreotti F, Anker SD, Filippatos G, Homma S, et al. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm. Thromb Haemost. 2012;108(12):1009\u201322.","journal-title":"Thromb Haemost"},{"issue":"2","key":"1203_CR85","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120\u20139.","journal-title":"N Engl J Med"},{"issue":"11","key":"1203_CR86","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10654-010-9520-y","volume":"25","author":"VP Alberts","year":"2010","unstructured":"Alberts VP, Bos MJ, Koudstaal P, Hofman A, Witteman JC, Stricker B, et al. Heart failure and the risk of stroke: the Rotterdam Study. Eur J Epidemiol. 2010;25(11):807\u201312.","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"1203_CR87","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/STROKEAHA.116.016022","volume":"48","author":"K Adelborg","year":"2017","unstructured":"Adelborg K, Sz\u00e9pligeti S, Sundb\u00f8ll J, Horv\u00e1th-Puh\u00f3 E, Henderson VW, Ording A, et al. Risk of stroke in patients with heart failure. Stroke. 2017;48(5):1161\u20138.\u00a0Population-based cohort study investigating risk of ischemic and hemorrhagic strokes in patients with heart failure.","journal-title":"Stroke"},{"issue":"9","key":"1203_CR88","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/cvr\/20.9.665","volume":"20","author":"N Tomioka","year":"1986","unstructured":"Tomioka N, Kishimoto C, Matsumori A, Kawai C. Mural thrombus in experimental viral myocarditis in mice: relation between thrombosis and congestive heart failure. Cardiovasc Res. 1986;20(9):665\u201371.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"1203_CR89","first-page":"10","volume":"73","author":"LB Mitrofanova","year":"2011","unstructured":"Mitrofanova LB, Koval\u2019ski\u012d GB. Myocardial morphological changes in atrial fibrillation. Arkh Patol. 2011;73(6):10\u20134.","journal-title":"Arkh Patol."},{"issue":"4","key":"1203_CR90","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1161\/01.CIR.96.4.1180","volume":"96","author":"A Frustaci","year":"1997","unstructured":"Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96(4):1180\u20134.","journal-title":"Circulation"},{"issue":"4","key":"1203_CR91","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1136\/hrt.2003.015347","volume":"90","author":"A Boldt","year":"2004","unstructured":"Boldt A, Wetzel U, Lauschke J, Weigl J, Gummert J, Hindricks G, et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart. 2004;90(4):400\u20135.","journal-title":"Heart"},{"key":"1203_CR92","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fcvm.2020.00011","volume":"7","author":"A Darlington","year":"2020","unstructured":"Darlington A, McCauley MD. Atrial cardiomyopathy: an unexplored limb of Virchow\u2019s triad for AF stroke prophylaxis. Front Cardiovasc Med. 2020;7:11. https:\/\/doi.org\/10.3389\/fcvm.2020.00011.","journal-title":"Front Cardiovasc Med."},{"issue":"9658","key":"1203_CR93","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","volume":"373","author":"T Watson","year":"2009","unstructured":"Watson T, Shantsila E, Lip GYH. Mechanisms of thrombogenesis in atrial fibrillation: Virchow\u2019s triad revisited. The Lancet. 2009;373(9658):155\u201366.","journal-title":"The Lancet"},{"issue":"4","key":"1203_CR94","first-page":"e15","volume":"127","author":"JA Reiffel","year":"2014","unstructured":"Reiffel JA. Atrial fibrillation and stroke: epidemiology. Am J Med. 2014;127(4):e15\u20136.","journal-title":"Am J Med"},{"issue":"2","key":"1203_CR95","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263\u201372.","journal-title":"Chest"},{"issue":"2","key":"1203_CR96","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019;140(2):e125\u201351.","journal-title":"Circulation"},{"issue":"5","key":"1203_CR97","first-page":"401","volume":"6","author":"KE Van Nuys","year":"2018","unstructured":"Van Nuys KE, Xie Z, Tysinger B, Hlatky MA, Goldman DP. Innovation in heart failure treatment: life expectancy, disability, and health disparities. JACC: Heart Failure. 2018;6(5):401\u20139.","journal-title":"JACC: Heart Failure."},{"issue":"5","key":"1203_CR98","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1046\/j.1445-5994.2001.00067.x","volume":"31","author":"OP Almeida","year":"2001","unstructured":"Almeida OP, Flicker L. The mind of a failing heart: a systematic review of the association between congestive heart failure and cognitive functioning. Intern Med J. 2001;31(5):290\u20135.","journal-title":"Intern Med J"},{"issue":"6","key":"1203_CR99","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s11886-012-0304-8","volume":"14","author":"H Muqtadar","year":"2012","unstructured":"Muqtadar H, Testai FD, Gorelick PB. The dementia of cardiac disease. Curr Cardiol Rep. 2012;14(6):732\u201340.","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"1203_CR100","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/gerona\/59.3.M268","volume":"59","author":"RS Tilvis","year":"2004","unstructured":"Tilvis RS, K\u00e4h\u00f6nen-V\u00e4re MH, Jolkkonen J, Valvanne J, Pitkala KH, Strandberg TE. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci. 2004;59(3):268\u201374.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"1203_CR101","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/archneurol.2011.163","volume":"68","author":"JR Festa","year":"2011","unstructured":"Festa JR, Jia X, Cheung K, Marchidann A, Schmidt M, Shapiro PA, et al. Association of low ejection fraction with impaired verbal memory in older patients with heart failure. Arch Neurol. 2011;68(8):1021\u20136.","journal-title":"Arch Neurol"},{"issue":"2","key":"1203_CR102","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ejhf.660","volume":"19","author":"CD Erkelens","year":"2017","unstructured":"Erkelens CD, van der Wal HH, de Jong BM, Elting JW, Renken R, Gerritsen M, et al. Dynamics of cerebral blood flow in patients with mild non-ischaemic heart failure. Eur J Heart Fail. 2017;19(2):261\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"1203_CR103","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/archinte.166.9.1003","volume":"166","author":"C Qiu","year":"2006","unstructured":"Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L. Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med. 2006;166(9):1003\u20138.","journal-title":"Arch Intern Med"},{"key":"1203_CR104","doi-asserted-by":"crossref","unstructured":"Woo MA, Macey PM, Fonarow GC, Hamilton MA, Harper RM. Regional brain gray matter loss in heart failure. J Appl Physiol (1985). 2003;95(2):677\u201384.","DOI":"10.1152\/japplphysiol.00101.2003"},{"issue":"3","key":"1203_CR105","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.neurobiolaging.2006.01.001","volume":"28","author":"AL Jefferson","year":"2007","unstructured":"Jefferson AL, Poppas A, Paul RH, Cohen RA. Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging. 2007;28(3):477\u201383.","journal-title":"Neurobiol Aging"},{"key":"1203_CR106","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/B978-0-12-819814-8.00023-8","volume":"177","author":"KL Miller","year":"2021","unstructured":"Miller KL, Pedelty L, Testai FD. The relationship between heart disease and cognitive impairment. Handb Clin Neurol. 2021;177:377\u201391.\u00a0Article investigating the relationship between vascular risk factors, heart disease, and cognitive decline.","journal-title":"Handb Clin Neurol"},{"issue":"8","key":"1203_CR107","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/j.1532-5415.2011.03508.x","volume":"59","author":"S Dublin","year":"2011","unstructured":"Dublin S, Anderson ML, Haneuse SJ, Heckbert SR, Crane PK, Breitner JC, et al. Atrial fibrillation and risk of dementia: a prospective cohort study. J Am Geriatr Soc. 2011;59(8):1369\u201375.","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"1203_CR108","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1007\/s11606-021-06954-8","volume":"36","author":"CA Papanastasiou","year":"2021","unstructured":"Papanastasiou CA, Theochari CA, Zareifopoulos N, Arfaras-Melainis A, Giannakoulas G, Karamitsos TD, et al. Atrial fibrillation is associated with cognitive impairment, all-cause dementia, vascular dementia, and Alzheimer\u2019s disease: a systematic review and meta-analysis. J Gen Intern Med. 2021;36(10):3122\u201335.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"1203_CR109","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1212\/WNL.0b013e31820f2e38","volume":"76","author":"CS Kwok","year":"2011","unstructured":"Kwok CS, Loke YK, Hale R, Potter JF, Myint PK. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology. 2011;76(10):914\u201322.","journal-title":"Neurology"},{"issue":"9","key":"1203_CR110","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7326\/M14-0538","volume":"161","author":"S Kalantarian","year":"2014","unstructured":"Kalantarian S, Ay H, Gollub RL, Lee H, Retzepi K, Mansour M, et al. Association between atrial fibrillation and silent cerebral infarctions: a systematic review and meta-analysis. Ann Intern Med. 2014;161(9):650\u20138.","journal-title":"Ann Intern Med"},{"issue":"10","key":"1203_CR111","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1056\/NEJM200003093421003","volume":"342","author":"RE McCarthy 3rd","year":"2000","unstructured":"McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000;342(10):690\u20135.","journal-title":"N Engl J Med"},{"issue":"4","key":"1203_CR112","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3988\/jcn.2015.11.4.383","volume":"11","author":"DM Nasr","year":"2015","unstructured":"Nasr DM, Rabinstein AA. Neurologic complications of extracorporeal membrane oxygenation. J Clin Neurol (Seoul, Korea). 2015;11(4):383\u20139.","journal-title":"J Clin Neurol (Seoul, Korea)"},{"issue":"12","key":"1203_CR113","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1097\/01.CCM.0000189940.70617.C3","volume":"33","author":"P Cengiz","year":"2005","unstructured":"Cengiz P, Seidel K, Rycus PT, Brogan TV, Roberts JS. Central nervous system complications during pediatric extracorporeal life support: incidence and risk factors. Crit Care Med. 2005;33(12):2817\u201324.","journal-title":"Crit Care Med"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-022-01203-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-022-01203-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-022-01203-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:00:39Z","timestamp":1744200039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-022-01203-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":113,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1203"],"URL":"https:\/\/doi.org\/10.1007\/s11910-022-01203-9","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"assertion":[{"value":"26 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Gabriela Trifan and Fernando D. Testai each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}